Fetal-maternal transfusion following early abortion.
Therapeutic abortion has been a major potential source of Rh isoimmunization. Popularization of early termination necessitates reconfirmation of established policies. This study involved 75 patients, selected at random, in whom pre- and post-abortion blood smears were studied for fetal-maternal hemorrhage. Results showed that this may occur even in early suction termination. The significance of these findings was discussed in relation to the cost-effectiveness and the dosage of anti-Rho (D) globulin administered to patients.
D000032:Abortion, Therapeutic / Q000191:economics; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage; D000917:Antibody Formation; D005260:Female; D005331:Fetomaternal Transfusion / Q000209:etiology*; D005865:Gestational Age; D006801:Humans; D007518:Isoantibodies; D011183:Postoperative Complications / Q000191:economics / Q000517:prevention & control; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012204:Rh-Hr Blood-Group System; D012306:Risk
D000888:Antibodies, Anti-Idiotypic; D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System